Business, energy, technology, markets and global industry news from Business News Today

nitinol

PharmaDeviceNews nitinol
Medical Devices & Diagnostics

Organon reports 3.9% six-year pregnancy rate with hormone-free MIUDELLA IUD

Organon has reported a cumulative six-year Pearl Index of 0.93 and an estimated pregnancy rate of 3.9% for the hormone-free MIUDELLA intrauterine system. The findings support an FDA application to extend its approved use from three to six years, with a decision expected in the second quarter of 2027.

Read More
Medical Devices & Diagnostics

Corcym implants first TriMemo tricuspid ring. Can surgical repair keep pace with transcatheter therapy?

Cleveland Clinic has completed the first human implantation of Corcym’s TriMemo annuloplasty ring, moving a purpose-built Nitinol platform into tricuspid repair as cardiac surgery faces growing competition from transcatheter structural-heart therapies.

Read More
Mitria Medical's Subvalvular Spacer reaches U.S. patients under FDA expanded access at Cleveland Clinic
Medical Devices & Diagnostics

How Mitria Medical’s nitinol spacer challenges the edge-to-edge repair model for functional mitral regurgitation

Mitria Medical's Subvalvular Spacer reaches the U.S. under FDA compassionate use. What it means for FMR patients and what clinical evidence still needs to come.

Read More